Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Carl Zeiss Meditec AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/02/2019 | 02:05am EDT

DGAP Preliminary announcement financial reports: Carl Zeiss Meditec AG / Preliminary announcement on the disclosure of financial statements
Carl Zeiss Meditec AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

02.08.2019 / 08:00
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Carl Zeiss Meditec AG hereby announces that the following financial reports shall be disclosed :

Report: Quarterly/ Interim statement within the 2nd half-year Date of disclosure / German: August 09, 2019 Date of disclosure / English: August 09, 2019 German: https://applications.zeiss.com/C1257A290053AE30/0/8978DC8CA72C51B7C1258423002496C9/$FILE/q3-quartalsmitteilung.pdf English: https://applications.zeiss.com/C1257A290053AE30/0/8C10FA84BE60BC68C12584230024B764/$FILE/q3-quarterly-statement.pdf



02.08.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Internet: www.zeiss.de/meditec-ag/ir

 
End of News DGAP News Service

833939  02.08.2019 

fncls.ssp?fn=show_t_gif&application_id=833939&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CARL ZEISS MEDITEC AG
08/12CARL ZEISS MEDITEC : continues strong growth trend after nine months of 2018/19
AQ
08/09EUROPE : Italy leads European shares lower on political uncertainty
RE
08/09GLOBAL MARKETS LIVE : Bayer, Huawei, Airbus, Occidental Petroleum…
08/09CARL ZEISS MEDITEC : continues strong growth trend after nine months of 2018/19
EQ
08/02CARL ZEISS MEDITEC AG : Preliminary announcement of the publication of quarterly..
EQ
07/16INFORMATION PURSUANT : Carl Zeiss Meditec is aiming for the upper end of its rev..
PU
07/15CARL ZEISS MEDITEC : is aiming for the upper end of its revenue forecast for the..
EQ
06/19EUROPE : European stocks tread water, all eyes on Fed
RE
06/18A pivotal month of June
06/04A war on all fronts
More news
Financials (EUR)
Sales 2019 1 428 M
EBIT 2019 264 M
Net income 2019 168 M
Finance 2019 665 M
Yield 2019 0,65%
P/E ratio 2019 54,2x
P/E ratio 2020 46,4x
EV / Sales2019 6,00x
EV / Sales2020 5,46x
Capitalization 9 239 M
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 92,38  €
Last Close Price 102,60  €
Spread / Highest target -2,53%
Spread / Average Target -9,96%
Spread / Lowest Target -20,1%
EPS Revisions
Managers
NameTitle
Ludwin Monz President & Chief Executive Officer
Michael Kaschke Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Markus Guthoff Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CARL ZEISS MEDITEC AG51.24%10 221
THERMO FISHER SCIENTIFIC31.80%117 223
DANAHER CORPORATION39.59%102 103
INTUITIVE SURGICAL10.83%61 104
BOSTON SCIENTIFIC CORPORATION21.39%58 951
EDWARDS LIFESCIENCES CORPORATION42.22%45 633